CY1490A - Improvements in or relating to nasal pharmaceutical compositions - Google Patents
Improvements in or relating to nasal pharmaceutical compositionsInfo
- Publication number
- CY1490A CY1490A CY149083A CY149083A CY1490A CY 1490 A CY1490 A CY 1490A CY 149083 A CY149083 A CY 149083A CY 149083 A CY149083 A CY 149083A CY 1490 A CY1490 A CY 1490A
- Authority
- CY
- Cyprus
- Prior art keywords
- relating
- pharmaceutical compositions
- nasal pharmaceutical
- nasal
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8202781 | 1982-02-01 | ||
GB08302374A GB2114001B (en) | 1982-02-01 | 1983-01-28 | Nasel pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1490A true CY1490A (en) | 1990-02-16 |
Family
ID=26281857
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY149083A CY1490A (en) | 1982-02-01 | 1983-01-28 | Improvements in or relating to nasal pharmaceutical compositions |
Country Status (2)
Country | Link |
---|---|
CY (1) | CY1490A (en) |
GB (1) | GB2114001B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT396870B (en) * | 1986-08-07 | 1993-12-27 | Sandoz Ag | Process for the production of a pharmaceutical formulation for the nasal administration of serotonin antagonists |
IL91856A0 (en) * | 1988-10-11 | 1990-06-10 | Schiapparelli Salute Spa | Pharmaceutical compositions comprising calcitonin for intranasal administration and a spray unit for the administration of the same |
US9314465B2 (en) | 2009-06-16 | 2016-04-19 | Infirst Healthcare Limited | Drug combinations and uses in treating a coughing condition |
GB0910375D0 (en) | 2009-06-16 | 2009-07-29 | Biocopea Ltd | Drug composition and its use in therapy |
US10016437B2 (en) | 2009-06-16 | 2018-07-10 | Infirst Healthcare Limited | Drug combinations and uses in treating a coughing condition |
US9308211B2 (en) | 2009-06-16 | 2016-04-12 | Infirst Healthcare Limited | Drug combinations and uses in treating a coughing condition |
-
1983
- 1983-01-28 CY CY149083A patent/CY1490A/en unknown
- 1983-01-28 GB GB08302374A patent/GB2114001B/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
GB8302374D0 (en) | 1983-03-02 |
GB2114001A (en) | 1983-08-17 |
GB2114001B (en) | 1986-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2117703B (en) | Improvements in or relating to fire-barriers | |
GB8326565D0 (en) | Pharmaceutical compositions | |
GB8327612D0 (en) | Pharmaceutical compositions | |
GB8318564D0 (en) | Pharmaceutical dermal compositions | |
IL70075A0 (en) | Improvements in or relating to 3-aryl-5-pyrazole derivatives | |
ZA834074B (en) | Pharmaceutical composition | |
EP0093551A3 (en) | Pharmaceutical composition | |
GB2118176B (en) | Pharmaceutical compositions | |
GB2117766B (en) | Pharmaceutical compositions | |
PT77323A (en) | Pharmaceutical compositions | |
GB8429749D0 (en) | Pharmaceutical compositions | |
CY1490A (en) | Improvements in or relating to nasal pharmaceutical compositions | |
GB8313814D0 (en) | Pharmaceutical compositions | |
GB8329700D0 (en) | Anti-haemophilic pharmaceutical composition | |
DE3377696D1 (en) | Pharmaceutical compositions | |
GB8328896D0 (en) | Pharmaceutical composition | |
GB2134577B (en) | Improvements in or relating to roadsigns | |
GB2118587B (en) | Improvements in or relating to structures | |
HK59989A (en) | Improvements in or relating to nasal pharmaceutical compositions | |
GB8305028D0 (en) | Pharmaceutical compositions | |
GB8332653D0 (en) | Pharmaceutical composition | |
GB8314736D0 (en) | Pharmaceutical compositions | |
GB8330810D0 (en) | Pharmaceutical compositions | |
GB8331068D0 (en) | Pharmaceutical compositions | |
IL68500A0 (en) | Improvement in or relating to naphthalenamine derivatives |